SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (3997)6/5/2001 8:25:16 PM
From: Michael Young  Read Replies (1) | Respond to of 52153
 
What the hell are you talking about?

I'm not that guy, whoever he is.

MIKE



To: Miljenko Zuanic who wrote (3997)6/5/2001 9:42:03 PM
From: Spekulatius  Read Replies (2) | Respond to of 52153
 
Maybe there are better times ahead for GZTC shareholder, now that M. Young and CEO S. Lehrmann are gone.
I expected the stock to go down after the CEO resignation but that did not happen - a sure sign that the management competency was not rated very high.
I do own GZTC and think it has a very good potential, all the Antibodies that are currently being tested must be produced somehow. GZTC may have the most economical way to do that, IMO.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News